HIND Vyome Holdings, Inc.
Healthcare$2.31+3.77%ClosedMarket Cap: $13.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.96
P/S
9.34
EV/EBITDA
-0.70
DCF Value
$1.84
FCF Yield
-24.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.2%
Operating Margin
-401.9%
Net Margin
-985.5%
ROE
-302.1%
ROA
-130.1%
ROIC
-67.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $31.6K | 44.4% | $-1.1M | $-962.9K | $— | — |
| Q4 null | $36.6K | 53.0% | $-1.4M | $-1.2M | $— | — |
| FY null | $319.7K | 64.7% | $-2.7M | $-10.3M | $— | — |
| Q3 null | $34.6K | 44.0% | $-868.8K | $-8.4M | $— | — |
| Q2 null | $1.2M | 48.2% | $-2.1M | $-2.6M | $— | — |
| Q1 null | $1.1M | 61.2% | $-2.2M | $1.5M | $— | — |
| Q4 null | $1.8M | 73.1% | $-1.7M | $-1.8M | $— | — |
| FY null | $8.0M | 63.2% | $-7.7M | $-7.1M | $— | — |
| Q3 null | $2.3M | 62.8% | $-1.8M | $-1.6M | $— | — |
| Q2 null | $2.0M | 57.7% | $-2.1M | $-1.6M | $— | — |
| Q1 null | $1.9M | 59.9% | $-2.2M | $-2.2M | $— | — |
| Q4 2023 | $2.0M | 92.9% | $-1.9M | $-1.7M | $-104.97 | — |